We are live on ! Find out more
SMMT icon

Summit Therapeutics
SMMT

37 hedge funds and large institutions have $42.9M invested in Summit Therapeutics in 2020 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

380% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 5

95% more funds holding

Funds holding: 19 → 37 (+18)

59% more capital invested

Capital invested by funds: $27M → $42.9M (+$15.9M)

8.77% more ownership

Funds ownership: 2.33% → 11.09% (+8.8%)

0% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 4

Holders
37
Holders Change
+18
Holders Change %
+94.74%
% of All Funds
0.65%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
24
Increased
4
Reduced
4
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$3.09M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$2.33M
3
ECM
ExodusPoint Capital Management
New York
+$787K
4
Morgan Stanley
Morgan Stanley
New York
+$187K
5
Capstone Investment Advisors
Capstone Investment Advisors
New York
+$158K

Top Sellers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
-$4.54M
2
Renaissance Technologies
Renaissance Technologies
New York
-$213K
3
MFS
Mirabella Financial Services
United Kingdom
-$125K
4
HSBC Holdings
HSBC Holdings
United Kingdom
-$94K
5
HF
HRT Financial
New York
-$62K
Name Holding Trade Value Shares
Change 		Change in
Stake
Citigroup
26
Citigroup
New York
$13K +$10.5K +2,474 +1,237%
RE
27
RBC Europe
United Kingdom
$9.26K +$8.34K +1,970 New
SPIA
28
Steward Partners Investment Advisory
New York
$9K +$8.47K +2,000 New
PCM
29
Penserra Capital Management
California
$9K +$8.62K +2,035 New
LC
30
Lindbrook Capital
California
$4K +$3.57K +843 New
ASN
31
Advisory Services Network
Georgia
$3K -$29.6K -7,000 -92%
QCG
32
Quadrant Capital Group
Ohio
$2K +$1.5K +354 New
S
33
SignatureFD
Georgia
$2K +$1.72K +406 New
CG
34
Cutler Group
California
$2K +$2.54K +600 New
Daiwa Securities Group
35
Daiwa Securities Group
Japan
$1K +$656 +155 New
US Bancorp
36
US Bancorp
Minnesota
$1K +$915 +216 New
PA
37
Parallel Advisors
California
$1K +$1.05K +247 New
MFS
38
Mirabella Financial Services
United Kingdom
– -$125K -36,380 Closed
HSBC Holdings
39
HSBC Holdings
United Kingdom
– -$94K -27,342 Closed
HF
40
HRT Financial
New York
– -$62K -18,119 Closed
APA
41
American Portfolios Advisors
New York
– -$3.44K -1,000 Closed
Group One Trading
42
Group One Trading
Illinois
– -$1K -400 Closed
1
2

SMMT Hedge Fund Activity: Q4 2020 in Review

37 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Summit Therapeutics (SMMT) for Q4 2020, worth a combined $42.9M — up 59% from $27M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new SMMT positions and 5 closed out — a net gain of 19 holders — while 4 added to existing stakes and 4 trimmed.

The largest buyer was BlackRock, opening a new position worth an estimated $3.09M. The largest seller was JP Morgan Chase, cutting an estimated $4.54M.

  • 37 institutional investors held Summit Therapeutics (SMMT) as of Q4 2020, up from 19 in Q3 2020.
  • Funds reported $42.9M of Summit Therapeutics stock for Q4 2020, up 59% quarter-over-quarter.
  • 24 funds opened new Summit Therapeutics positions in Q4 2020 and 5 closed out, a net change of +19 holders.
  • The largest Summit Therapeutics buyer in Q4 2020 was BlackRock, an estimated $3.09M added.
  • The largest Summit Therapeutics seller in Q4 2020 was JP Morgan Chase, an estimated $4.54M sold.

Based on aggregated 13F filings for Q4 2020.